Vaxine advances global health with its innovative vaccines developed with the help of artificial intelligence

Vaccine Development

Vaxine is actively engaged in developing its own vaccine portfolio.

Advax™ Adjuvant Platform

We develop a patented, delta inulin polysaccharide adjuvant platform.

Intern Program

We run an intern program which is highly sought after by biotechnology Masters degree students.

Our Projects

COVID-19Vaxine has a long history of coronavirus vaccine development supported by almost two decades of competitive research funding from the US National Institutes of Health. 
InfluenzaSeasonal influenza continues to be a major public health burden, causing an estimated 300,000 – 600,000 deaths globally each year.
RSVRespiratory Syncytial Virus is the second most common cause of serious viral respiratory disease after influenza.
Hepatitis BHepatitis B (HBV) is the world’s most common liver infection and can lead to cirrhosis and liver cancer. 
JEVJapanese encephalitis virus (JEV) is a mosquito-borne flavivirus that can cause fatal encephalitis in humans and horses.
MalariaMalaria remains a major global health issue, affecting hundreds of millions of individuals globally.
EbolaEbola is one of the world’s most lethal viral infections, with a mortality rate of greater than 80% amongst infected individuals. 
TuberculousTuberculous remains a major cause of lung disease particularly in developing countries but is also a problem in individuals with immune-deficiency including those suffering from HIV infection. 
AnthraxAlthough naturally occurring human anthrax infection has become uncommon, concern over the use of anthrax as a biological weapon of mass destruction and remains at high levels. 
HIVAfter almost 40 years of intensive research, there have been considerable breakthroughs in understanding the nature of the HIV virus, but nevertheless a preventative vaccine remains elusive.
AllergyCurrently the only solution for people who suffer from serious life threatening insect bite allergies, such as bee or ant venom allergy, is to carry an Epipen or to undertake long term frequent injections of venom to induce desensitisation.
Cancer ImmunotherapyVaxine has developed a number of potent innate immune activators (toll-like receptor agonists) that can be injected directly into a patients tumour, and thereby help activate T cells in the tumour to attack it. 
ShigellaShigellosis is an intestinal disease characterised by bloody diarrhoea, caused by bacteria known as shigella.
Opioid AddictionOpioid addition is a growing problem globally. One potential strategy to counter this problem is to develop an opioid vaccine. 
Alzheimer's DiseaseAlzheimer’s disease is a growing global issue with the ageing of global populations.
Zika VirusZika is a flavi-virus that has recently been shown to cause foetal malformations if pregnant women become infected.
Typhoid FeverTyphoid fever remains endemic in many parts of the developing world and still kills many young children.
Looking to learn more about our projects?
Learn more

Our Offices

Proudly located in Adelaide, South Australia.

Locate Us

Contact Us

You may contact us by filling in this form any time you need professional support.

Fill Our Form

Careers

We are looking for intelligent, curious biotech professionals to join us.

See Our People